Peoples Bk of Com Or (PBCO) 9.4500 $PBCO People's Bank

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Peoples Bk of Com Or (PBCO) 9.4500 $PBCO

People's Bank of Commerce Declares Dividend, Releases Earnings
BusinessWire - Wed Apr 20, 12:11PM CDT
People's Bank of Commerce (OTCBB: PBCO) announced today its financial results for the first quarter of 2016 and the last 12 months of operations. The bank reported net income of $298,000 or $0.14 per diluted share for the first quarter of 2016, compared to net income of $335,000 or $0.17 per diluted share in the same quarter of 2015.

People's Bank of Commerce reports lower net income for Q4 2015 year over year
M2 - Thu Jan 21, 4:45AM CST
People's Bank of Commerce (OTCBBBCO) on Thursday reported net income of USD224,000 or USD0.10 per diluted share for the quarter ended 31 December 2015, down from the net income of USD323,000 or USD0.15 per diluted share for the same period in 2014.

People's Bank of Commerce Reports 17% Increase in Net Income
BusinessWire - Wed Jan 20, 7:38PM CST
People's Bank of Commerce (OTCBBBCO) announced today its financial results for the quarter and year ending December 31, 2015. The bank reported net income of $1,405,000 or $0.65 per diluted share for the year 2015, compared to net income of $1,196,000 or $0.57 per diluted share in 2014. Net income for the fourth quarter of 2015 was $224,000 or $0.10 per diluted share, compared to $323,000 or $0.15 per diluted share for the same period in 2014.

People's Bank reports 29% increase in net income for Q3 2015 year over year
M2 - Thu Oct 22, 6:29AM CDT
People's Bank of Commerce (OTCBBBCO) on Thursday reported for the third quarter of 2015 net earnings of USD472,000 or USD0.22 per share, an increase of 29% compared to the net earnings of USD367,000 or USD0.17 per share for the same period in 2014.

People's Bank Reports 35% Increase in Earnings
BusinessWire - Wed Oct 21, 6:08PM CDT
People's Bank of Commerce (OTCBBBCO) today reported earnings of $1,181,000 for the first nine months of 2015, up 35% compared to $874,000 for the same period last year. This resulted in earnings of $0.57 per share for the first nine months of 2015, compared to $0.44 per share reported the prior year. Net interest income was up by 14% year-to-date, the result of continued loan growth during 2015. Portfolio loan and deposit growth in the past 12 months continues in excess of 11% and 12%, respectively. "In addition to improving economic conditions, consolidation and merger activities of larger banks have led to more commercial loan opportunities for People's Bank," said John Boyd, Chief Credit Officer.

People's Bank Declares a Special 5% Stock Dividend
BusinessWire - Wed Aug 05, 1:19PM CDT
The board of directors of People's Bank of Commerce (OTCBBBCO) announced that it has declared a one-time five percent stock dividend. This special dividend will be paid on or about September 17, 2015 to shareholders of record August 17, 2015. This unique mid-year stock dividend rewards our shareholders for the strong earnings attained for the first six months of 2015. June 30, 2015 also marks the bank's 24th consecutive quarter of profitability since the recession began.

People's Bank Reports 64 Percent Increase in 1st Quarter Earnings
BusinessWire - Tue Apr 21, 6:25PM CDT
People's Bank of Commerce (OTCBB: PBCO) reported today that its earnings for the first quarter of 2015 were $335,000 compared to $204,000 during the first quarter of 2014. The bank reported earnings of $0.17 per share for the three months ending March 31, 2015, compared to $0.11 per share in 2014. People's Bank experienced a 20 percent increase in net interest income in the first quarter of 2015 when compared to the same period last year. Non-interest income was up 20 percent from the prior year during the first quarter of 2015, primarily due to an increase in mortgage loan and service charge income.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Ameripath USA Collaborates with Recovery Resolutions to Support Recovery Housing

Updated Category News Views 308

Ameripath USA's New Partnership for Recovery Housing Ameripath USA has formed a strategic partnership with Recovery Resolutions LLC to significantly improve access to high-quality Addiction Recovery Homes throughout the country. This collaboration merges Ameripath's extensive real estate expertise with Recovery Resolutions' impressive success model, boasting a 95% success...

Continue Reading
Finzly’s ISO 20022 Migration Readiness Sets Industry Standards

Updated Category News Views 311

Finzly’s Innovations in ISO 20022 Payment Standards Finzly is at the forefront of transforming how financial institutions manage payments through its state-of-the-art platform designed for modern banking needs. As the shift to SWIFT MX ISO 20022 continues, Finzly's clientele is emerging as early adopters, demonstrating a commitment to embracing new technologies that...

Continue Reading
Innovative Drug Delivery Solutions for Parkinson's Disease

Updated Category News Views 251

Serina Therapeutics' Approach to Parkinson's Disease Serina Therapeutics is at the forefront of developing new treatments for complex neurological disorders, particularly Parkinson’s disease. This progressive neurological disorder significantly impacts motor functions and quality of life for those affected. With innovative solutions on the horizon, Serina is prepared to...

Continue Reading
Waters Corporation Leader to Speak at HealthCONx Conference

Updated Category News Views 124

Waters Corporation to Participate in HealthCONx Conference Waters Corporation (NYSE: WAT), located in Milford, Massachusetts, is pleased to announce its participation in the upcoming HealthCONx Conference. Udit Batra, the President and Chief Executive Officer of Waters, will engage in an insightful fireside chat set for Wednesday, December 4th, 2024, at 10:00 AM Eastern...

Continue Reading
mRNA Synthesis and Manufacturing Market Expected to Grow Steadily

Updated Category News Views 33

Growing Insights into the mRNA Synthesis and Manufacturing Market The mRNA synthesis and manufacturing market is on a promising trajectory, with projections indicating substantial growth from USD 624.4 million to USD 738.3 million by 2029. This expansion translates into a compound annual growth rate (CAGR) of 3.4%. Several factors are propelling this growth, including an...

Continue Reading